Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dapeng Chen

Showing results (261-270 of 279) with videos related to

Pageof 28
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 30, 2016
MARK inhibitors: Declaring a No-Go decision on a chemical series based on extensive DMPK experimentationAndrew M Haidle, Kaleen K Childers, Anna A Zabierek, et al.
The Pediatric Infectious Disease Journal|September 11, 2021
Prevalence of Latent Tuberculosis Infection Among Healthy Young Children and Adolescents and a Two-step Approach for the Diagnosis of Tuberculosis Infection in Chengdu, ChinaJihang Jia, Dapeng Chen, Li Liu, et al.
Cell Chemical Biology|April 18, 2025
CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancersNicholas Kwiatkowski, Tong Liang, Zhe Sha, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2016
Structure guided design of a series of selective pyrrolopyrimidinone MARK inhibitorsJason D Katz, Andrew Haidle, Kaleen K Childers, et al.
Clinical Chemistry and Laboratory Medicine|May 24, 2022
Age and sex specific reference intervals of 13 hematological analytes in Chinese children and adolescents aged from 28 days up to 20 years: the PRINCE studyWenqi Song, Ruohua Yan, Mingting Peng, et al.
The Journal of Clinical Investigation|September 26, 2024
YTHDF1 loss in dendritic cells potentiates radiation-induced antitumor immunity via STING-dependent type I IFN productionChuangyu Wen, Liangliang Wang, András Piffkó, et al.
Journal of Medicinal Chemistry|June 26, 2024
Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell LymphomaMatthew M Weiss, Xiaozhang Zheng, Nan Ji, et al.
Clinical Chemistry and Laboratory Medicine|August 8, 2022
Reference intervals of 14 biochemical markers for children and adolescence in China: the PRINCE studyXiaoxia Peng, Yaguang Peng, Chuanbao Zhang, et al.
Nature|November 10, 2025
Publisher Correction: Radiation-induced amphiregulin drives tumour metastasisAndrás Piffkó, Kaiting Yang, Arpit Panda, et al.
Nature|May 14, 2025
Radiation-induced amphiregulin drives tumour metastasisAndrás Piffkó, Kaiting Yang, Arpit Panda, et al.
Pageof 28

Showing results (261-270 of 279) with videos related to

Sort By:
Pageof 28
Bioorganic & Medicinal Chemistry Letters|November 30, 2016
MARK inhibitors: Declaring a No-Go decision on a chemical series based on extensive DMPK experimentationAndrew M Haidle, Kaleen K Childers, Anna A Zabierek, et al.
The Pediatric Infectious Disease Journal|September 11, 2021
Prevalence of Latent Tuberculosis Infection Among Healthy Young Children and Adolescents and a Two-step Approach for the Diagnosis of Tuberculosis Infection in Chengdu, ChinaJihang Jia, Dapeng Chen, Li Liu, et al.
Cell Chemical Biology|April 18, 2025
CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancersNicholas Kwiatkowski, Tong Liang, Zhe Sha, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2016
Structure guided design of a series of selective pyrrolopyrimidinone MARK inhibitorsJason D Katz, Andrew Haidle, Kaleen K Childers, et al.
Clinical Chemistry and Laboratory Medicine|May 24, 2022
Age and sex specific reference intervals of 13 hematological analytes in Chinese children and adolescents aged from 28 days up to 20 years: the PRINCE studyWenqi Song, Ruohua Yan, Mingting Peng, et al.
The Journal of Clinical Investigation|September 26, 2024
YTHDF1 loss in dendritic cells potentiates radiation-induced antitumor immunity via STING-dependent type I IFN productionChuangyu Wen, Liangliang Wang, András Piffkó, et al.
Journal of Medicinal Chemistry|June 26, 2024
Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell LymphomaMatthew M Weiss, Xiaozhang Zheng, Nan Ji, et al.
Clinical Chemistry and Laboratory Medicine|August 8, 2022
Reference intervals of 14 biochemical markers for children and adolescence in China: the PRINCE studyXiaoxia Peng, Yaguang Peng, Chuanbao Zhang, et al.
Nature|November 10, 2025
Publisher Correction: Radiation-induced amphiregulin drives tumour metastasisAndrás Piffkó, Kaiting Yang, Arpit Panda, et al.
Nature|May 14, 2025
Radiation-induced amphiregulin drives tumour metastasisAndrás Piffkó, Kaiting Yang, Arpit Panda, et al.
Pageof 28